Aug 9, 2019, 01:00 by admin admin

The American Society of Addiction Medicine (ASAM), the American Association of Nurse Practitioners (AANP), and the American Academy of Physician Assistants (AAPA) sent a letter to licensure boards in support of the provision of CARA that extends buprenorphine prescribing authority to NPs and PAs and asks for this information to be clearly communicated to licensed clinicians in the state.

Aug 9, 2019, 01:00 by admin admin

The Coalition to Stop Opioid Overdose (CSOO) is thrilled to announce The Kennedy Forum as the newest member of the coalition. Founded by the Honorable Patrick J. Kennedy, The Kennedy Forum seeks to set a new standard for the future of health care in the United States which unites the health care system and rallies the mental health community.

Aug 9, 2019, 01:00 by admin admin

WISAM president Dr. Galbis-Reig attended a press conference applauding a deal to remove prior authorization from certain medications for addiction treatment.

Aug 9, 2019, 01:00 by admin admin

Patients struggling with opioid addiction often live in rural areas where there are few to no providers who can prescribe medications that are controlled substances as part of a treatment plan to treat addiction. The growth in the use of telemedicine represents a remarkable opportunity to use new technologies to care for those who lack access to transportation or endure other geographical barriers.

Aug 9, 2019, 01:00 by admin admin

ASAM, in collaboration with the AMA and APA published an “Enhanced Attestation” form that payers and regulators can use to increase compliance with the Mental Health Parity and Addiction Equity Act (MHPAEA).

Aug 9, 2019, 01:00 by admin admin

ASAM submitted a comment letter to the Department of Health and Human Services’ Assistant Secretary for Planning and Evaluation (ASPE) in response to an RFI required by the Ensuring Patient Access and Effective Drug Enforcement Act of 2016.

Aug 9, 2019, 01:00 by admin admin

Washington, DC – ACOG, AAP, ASAM, March of Dimes and NOFAS released a statement in response to the policy instituted by the Big Horn County Attorney’s Office in Montana to prosecute and incarcerate pregnant women for drug/alcohol use.

Aug 9, 2019, 01:00 by admin admin

The briefing, titled “Transforming Addiction Treatment: A Bigger, Bolder Response to America’s Opioid Overdose Epidemic,” brought together experts working on the front lines of addiction treatment to discuss the comprehensive approach needed to stem the tide of a public health emergency that claimed 42,249 lives in 2016.

Aug 9, 2019, 01:00 by admin admin

Penny Mills, ASAM’s Executive Vice President (EVP) and CEO, has decided she will retire at the beginning of June 2020.

Aug 9, 2019, 01:00 by admin admin

The Coalition to Stop Opioid Overdose (CSOO) is excited to welcome the Academy of Integrative Pain Management (AIPM) as the newest member of the coalition. Founded in 1988, AIPM is a diverse community of healthcare providers representing more than 30 distinct disciplines who are dedicated to using all appropriate therapeutic approaches to reduce pain and achieve optimal health and healing.

Aug 9, 2019, 01:00 by admin admin

ASAM commends CMS for issuing this new guidance which expands access to care and requires states to align their section 1115(a) demonstrations with certain goals and milestones.

Aug 9, 2019, 01:00 by admin admin

The Coalition to Stop Opioid Overdose (CSOO) is pleased to announce the National Council for Behavioral Health (National Council) as a new member of the coalition. The National Council for Behavioral Health is the leading voice for health care organizations that deliver mental health, addiction treatment, and support services.

Aug 9, 2019, 01:00 by admin admin

Several weeks ago, ASAM contacted the CDC to discuss the persistence of misunderstandings surrounding dosage thresholds in the CDC Guidelines for Prescribing Opioids for Chronic Pain – 2016 (Guideline) and addiction medicine.

Aug 9, 2019, 01:00 by admin admin

Dr. Ilse Levin and Kelly Corredor attended the AMA's 2020 National Advocacy Conference.

Aug 9, 2019, 01:00 by admin admin

The dearth of FDA-approved pharmacotherapies for the treatment of substance use disorder (SUD) prompted ASAM to write to the Food and Drug Administration urging them to take into consideration the need for access to multiple treatment options for clinicians and their patients as they consider applications for new products to treat SUD.

Aug 9, 2019, 01:00 by admin admin

The Partnership to Amend 42 CFR Part 2 sent a letter urging Senator Lamar Alexander to help align 42 CFR Part 2 with HIPAA.

Aug 9, 2019, 01:00 by admin admin

The Centers for Disease Control and Prevention (CDC), the Food and Drug Administration (FDA) state and local health departments, and other clinical and public health partners are investigating a national outbreak of e-cigarette, or vaping, product use-associated lung injury (EVALI). As of December 10, 2019, a total of 2,409 hospitalized EVALI cases have been reported to CDC from all 50 states, the District of Columbia, and two U.S. territories (Puerto Rico and U.S. Virgin Islands). Fifty-two deaths have been confirmed in 26 states and the District of Columbia.

Aug 9, 2019, 01:00 by admin admin

On April 11, 2017, ASAM and 19 members of the Coalition to Stop Opioid Overdose sent a letter to the Chairmen and Ranking Members of the House and Senate Committees on Appropriations requesting full funding for the Comprehensive Addiction and Recovery Act (CARA) in the Fiscal Year 2017 and 2018 appropriations bills.

Aug 9, 2019, 01:00 by admin admin

The Coalition to Stop Opioid Overdose (CSOO) is pleased to welcome the American College of Medical Toxicology (ACMT) as a new member of the coalition. ACMT is a professional association of physicians who are Board Certified in Medical Toxicology. Since its inception in 1993, ACMT has worked to advance the practice of medical toxicology and advocates for the care of toxicologic patients and individuals with substance use disorders.

Aug 9, 2019, 01:00 by admin admin

Passage of Senate Opioid Package: Statement from the American Society of Addiction Medicine